HIV Positive Clinical Trial
Official title:
Complementary & Alternative Care Behavior in HIV+ Latinos in the US-Mexico Border
Verified date | February 2020 |
Source | University of California, San Diego |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The goal of The investigators community-based participatory research study is to identify the nature and extent of complementary and alternative medicine (CAM) use among HIV-positive Latinos on the San Diego/Tijuana border. CAM use among US Latinos living with HIV is associated with delayed utilization of and poor adherence to antiretroviral therapies (ARVs) that may exacerbate health disparities in HIV care access and health outcomes. This study will lead to development of culturally-effective interventions to improve access and adherence to HIV care in Latinos who face health disparities. The investigators hypothesis is that greater use of CAM will be observed among HIV-positive Latinos who report a) crossing the U.S. border more frequently, and b) having migrated to Tijuana or San Diego (e.g. from southern Mexico). The investigators also hypothesize that compared to HIV-positive Latinos who report using herbal CAM, those who do not use herbal CAM are more likely to be receiving ARVs and report higher levels of adherence to ARVs; Compared to HIV-positive Latinos who do not attend religious services regularly, those who attend religious services regularly are more likely to be receiving ARV; Compared to HIV- positive Latinos who report experiencing HIV related stigma, those who do not report experiencing HIV-related stigma are significantly more likely to be receiving ARVs.
Status | Completed |
Enrollment | 541 |
Est. completion date | January 2013 |
Est. primary completion date | January 2013 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Latino - Speak English or Spanish or both - Lived in San Diego or Tijuana for at least 1 month in the last year - 18 years or older - HIV-positive or living with AIDS Exclusion Criteria: - Non-Latino - Speak neither English nor Spanish - Have not lived in San Diego or Tijuana for at least 1 month in the last year - Under 18 years of age - Not HIV-positive or living with AIDS |
Country | Name | City | State |
---|---|---|---|
United States | San Ysidro Health Center | San Ysidro | California |
Lead Sponsor | Collaborator |
---|---|
University of California, San Diego | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00639145 -
Elizabeth Glaser Pediatric AIDS Foundation Maternal Events and Pregnancy Outcomes (MEP Project)A Multi-site Protocol
|
||
Completed |
NCT01957748 -
CCTG 594: Engagement and Retention in Care for HIV+
|
N/A | |
Completed |
NCT01818258 -
IMPAACT P1092: Steady State PK in Malnourished HIV Infected Children
|
Phase 4 | |
Withdrawn |
NCT03660722 -
Bone, Inflammation, Gut and Renal Biomarkers in Antiretroviral Naïve HIV-1 Positive Subjects
|
N/A | |
Completed |
NCT01793467 -
Transplantation and the Use of Raltegravir in HIV-Infected Patients
|
N/A | |
Completed |
NCT02938377 -
Alcohol Research Consortium in HIV-Intervention Research Arm
|
Phase 4 | |
Completed |
NCT01898754 -
Oligonucleotide Ligation Assay (OLA) Resistance Study
|
N/A | |
Active, not recruiting |
NCT01365065 -
Safety and Effect on HIV Transcription of Vorinostat in Patients Receiving Suppressive Combination Anti-retroviral Therapy
|
Phase 2 | |
Completed |
NCT00106795 -
Relationship Between Fatigue and Mitochondrial Damage in Patients With HIV/AIDS
|
N/A | |
Not yet recruiting |
NCT02404233 -
Open Label, Pilot Study of Darunavir Boosted by Cobicistat in Combination With Rilpivirine to Treat HIV+ Naïve Subjects
|
Phase 4 | |
Completed |
NCT01154543 -
Safety and Efficacy of Famciclovir in HIV1 Positive Adults With Recurrent Genital Herpes
|
N/A | |
Completed |
NCT01154556 -
RETRIeVE: ReversE TranscRiptase Inhibitor hiV Practice
|
N/A | |
Completed |
NCT00857350 -
The Prevalence of HIV Drug Resistance and Transmission Risk in Opioid Agonist Treatment
|
N/A | |
Recruiting |
NCT01875588 -
Thinking and Memory Problems in People With HIV
|
||
Completed |
NCT01941121 -
CCTG 593: Testing and Linkage to Care
|
N/A | |
Terminated |
NCT01904201 -
Evaluation of a Blood Test to Measure Immune Function in HIV Positive People Compared With HIV Negative People
|
N/A | |
Enrolling by invitation |
NCT00941889 -
The Effect of HPV Vaccination on Recurrence Rates in HIV Patients With Condylomata
|
N/A | |
Completed |
NCT03531749 -
Antioxidant in Patients HIV+ Supplemented With Microencapsulated of Red Pomegranate
|
N/A | |
Completed |
NCT02935296 -
Integrated Treatment and Prevention for People Who Inject Drugs
|
Phase 3 | |
Completed |
NCT01536912 -
Medical Marijuana Use in HIV+ Patients: Probability Survey
|
N/A |